ArticleJACC. Advances2024
Outcomes of Concomitant Atrial Fibrillation Ablation and Left Atrial Appendage Closure: A Retrospective Single-Center Experience.
Article in JACC. Advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Safety and Outcomes of Concomitant Left Atrial Appendage Occlusion and Atrial Fibrillation Ablation.JACC. Advances · 2026Article
- Triple Percutaneous Therapy for Mitral Regurgitation and Atrial Fibrillation.JACC. Case reports · 2026Article
- Occlusion effects, safety, and clinical prognosis of Watchman and LAmbre occluders in left atrial appendage closure.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Catheter ablation is an effective therapy in the management of atrial fibrillation (AF). Left atrial appendage closure (LAAC) is an alternative to anticoagulation for stroke prevention in patients with bleeding risks. Objectives: The purpose of this study was to assess the safety and efficacy of combining AF ablation and LAAC in a single procedure. Methods: This retrospective observational study included consecutive patients who underwent concomitant AF ablation and LAAC between June 2015 and August 2021. We assessed the safety and efficacy of the combined procedure with respect to procedural success, periprocedural complications, thromboembolism, bleeding, and arrhythmia recurrence. Results: A total of 178 patients (mean age 72.1 ± 8.7 years, 60.7% male) were identified. The mean CHA Conclusions: Concomitant AF ablation and LAAC could be considered in appropriate patients in centers of clinical expertise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.